Arisaph Pharmaceuticals

Arisaph Pharmaceuticals. Is an emerging biopharmaceutical firm focused on developing novel therapies for cancer, cardiovascular disease and diabetes. The firm utilizes proprietary drug discovery platforms to evolve differentiated medicines that are highly potent and act selectively on validated targets. Arisaph currently has seven active drug discovery programs in various stages of development.